oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma
Published 3 years ago • 1.5K plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:18
vinorelbine in mesothelioma: the upcoming vim trial
-
1:33
exciting randomized trials for mesothelioma: checkpoint inhibitor monotherapies and vinorelbine
-
3:33
immunotherapy for mesothelioma
-
2:12
atomic-meso: pegargiminase in malignant pleural mesothelioma
-
32:21
advances in the treatment of malignant pleural mesothelioma
-
1:31
mist: molecularly targeted therapy for malignant pleural mesothelioma
-
3:40
pembrolizumab showed clinical benefit in malignant pleural mesothelioma
-
1:34
phase 1b trial of crs-207 with chemotherapy for malignant pleural mesothelioma
-
2:59
promise-meso: pembrolizumab vs. standard chemotherapy for mesothelioma
-
0:58
what treatments are available for mesothelioma?
-
34:26
metronomic method of application of vinorelbine: to whom and when to appoint
-
28:27
multimodal approach to the treatment of patients with malignant pleural mesothelioma
-
16:56
place of oral vinorelbine in breast cancer therapy
-
4:33
pembrolizumab improves os in firstline treatment for unresectable advanced pleural mesothelioma
-
0:25
resectable mesothelioma #2023 #oncology #lungcancer
-
1:35
cutting-edge uk trials for mesothelioma: double immuno, arginine depletion and molecular profiling
-
8:45
survival in epithelioid malignant pleural mesothelioma
-
27:30
mesotv | clinical trial open: immunotherapy prior to surgery for resectable pleural mesothelioma
-
4:06
mesothelioma: how will novel immunotherapies impact surgery?